Viewing Study NCT06342297



Ignite Creation Date: 2024-05-06 @ 8:20 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06342297
Status: RECRUITING
Last Update Posted: 2024-04-02
First Post: 2024-03-26

Brief Title: Dermatoscopy Guided Resection for Skin Cancer
Sponsor: Region Örebro County
Organization: Region Örebro County

Study Overview

Official Title: Dermatoscopy Guided Resection Margins in Basal Cell Carcinoma and Cutaneos Squamous Cell Carcinoma
Status: RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In this randomizid controlled trial the aim is to use dermatoscopy in deciding the resection margin for patients with suspected or verified basal cell carcinoma or cutaneous squamous cell carcinoma The outcome is radicalnon radical resection of the lateral margins in the pathology report
Detailed Description: In basal cell carcinoma and especially cutaneous squamous cell carcinoma the prognosis is very good if the tumour is radically removed in the primary resection In this study we propose that the use of dermatoscopy in deciding the surgical margins can increase the proportion of radically removed tumours In this randomized clinical trial the use of dermatoscopy in deciding the surgical margins in patients with suspected or verified basal cell carcinoma or cutaneous squamous cell carcinoma is assessed The outcome measure is radicalnon radical resection of the lateral margins In the control group dematoscopy is not used in deciding the surgical margin 400 patients with suspected or verified BCC or cSCC will be included 200 in each group

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None